RUNX1 and metabolic dysfunction-associated steatohepatitis: RUNX1 expression was significantly correlated with inflammation, fibrosis, and NASH activity score in patients, while in vitro analyses suggested that steatosis-induced RUNX1 levels lead to upregulation of adhesion and angiogenic molecules in endothelial cells and may be involved in enhancing inflammation and disease severity in NASH.